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Abstract
Background: Anesthetic-induced CNS depression is thought to involve reduction of glutamate
release from nerve terminals. Recent studies suggest that isoflurane reduces glutamate release by
block of Na channels. To further investigate this question we examined the actions of isoflurane,
TTX, extracellular Ca2+, CNQX and stimulus voltage (stim) on glutamate-mediated transmission
at hippocampal excitatory synapses. EPSPs were recorded from CA1 neurons in rat hippocampal
brain slices in response to Schaffer-collateral fiber stimulation.
Results:  Isoflurane (350 µM; 1 MAC) reversibly depressed EPSP amplitudes by ~60% while
facilitation increased ~20%. Consistent with previous studies, these results indicate a presynaptic
site of action that involves reduced excitation-release coupling. EPSPs were depressed to
comparable levels by TTX (60 nM) or lowered stim, but facilitation was not changed, indicating a
simple failure of axonal conduction. Similarly, partial antagonism of postsynaptic glutamate
receptors with CNQX (10 µM) depressed EPSP amplitudes with no change in facilitation. However,
EPSP depression by low external Ca2+ (0.8 mM) was accompanied by an increase in facilitation
comparable to isoflurane. Isoflurane depression of EPSP amplitudes could also be partly reversed
by high external Ca2+ (4 mM) that also decreased facilitation. Isoflurane or low Ca2+ markedly
reduced the slopes of fiber volley (FV)-EPSP input-output curves, consistent with little or no effect
on FVs. By contrast, TTX didn't alter the FV-EPSP curve slope, indicating that EPSP depression
resulted from FV depression. FVs were remarkably resistant to isoflurane. Somatic spike currents
were unaffected by 350 µM (1 MAC) isoflurane as well. The EC50 for isoflurane depression of FVs
was ~2.8 mM (12 vol. %; 8 MAC).
Conclusion: Isoflurane appears to depress CA1 synapses at presynaptic sites downstream from
Na channels, as evident by the increased facilitation that accompanies EPSP depression. Fiber
volleys did not exhibit depression by isoflurane, as has been reported for other brain regions.
Background
A longstanding controversy in the anesthesia literature
concerns whether general anesthetics exert their actions
primarily by depression of synaptic transmission or by
blocking nerve conduction like local anesthetics. Thesleff
[1] first proposed that general and local anesthetics share
a common mechanism to block Na conductance [cf. [2-
4]]. Alternatively, other early studies yielded evidence that
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Enhancement of facilitation by isoflurane and low external Ca2+ but not by TTX Figure 1
Enhancement of facilitation by isoflurane and low external Ca2+ but not by TTX. A, (top left) an averaged extracellu-
lar recording showing two methods that were used for signal parameter measurement: a minimum-to-baseline (MTB) algo-
rithm was used to measure FV and EPSP amplitudes (dashed lines); a dV/dt (slope) algorithm was used to measure the initial 
slope of FVs (1) and EPSPs (2). A, (top right) comparison of slope and amplitude measures of FVs as a function of stimulus volt-
age. Open circles are FV amplitudes measured by MTB (r2 = 0.99; n = 60). Green circles are FV slope measurements that were 
scaled to match the amplitude data (r2 = 0.85; n = 60). Each data set was fit by linear regression (solid lines). A, (lower right) 
comparison of slope and amplitude measures of EPSPs as a function of stimulus voltage. Open circles are EPSP amplitudes (r2 = 
0.97; n = 30). Blue circles are EPSP slope measurements that were scaled to match the amplitude data (r2 = 0.83; n = 30). Solid 
lines represent fits by linear regression. A, (lower left) an experiment showing changes in FV amplitudes (gray circles) and scaled 
slopes (green triangles) as stimulus voltage was increased and decreased. EPSP amplitudes (open circles) are plotted together 
with scaled EPSP slopes (blue triangles). Although the stimulus voltage was changed over a 3–6 V range there was no change in 
facilitation (solid black line). B, Isoflurane depressed EPSPs (white and gray circles) and increased facilitation (black diamonds). 
C, Low external Ca2+ (0.8 mM) depressed EPSPs and increased facilitation. D, 60 nM TTX depressed EPSPs while facilitation 
remained unchanged. Note that changes in the stimulus voltage in all three experiments (appearing as ramps in EPSP ampli-
tudes) did not affect facilitation.BMC Neuroscience 2006, 7:5 http://www.biomedcentral.com/1471-2202/7/5
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volatile anesthetics preferentially depress synaptic poten-
tials rather than axonal conduction [5,6]. At present, most
studies of volatile anesthetic molecular targets are directed
toward synaptic ligand-gated ion channels, as these sites
appear more sensitive to volatile anesthetics than voltage-
gated channels [7]. However, other studies have shown
that volatile anesthetics depress axonal conduction or
block voltage-gated Na channels. Berg-Johnsen and Lang-
moen [8] reported that 1 MAC isoflurane (1.5 vol. %) pro-
duced an 18% depression of fiber volley amplitudes
recorded from small unmyelinated fibers in the hippoc-
ampal CA1 region. More recently, Mikulec et al. [9]
reported that 1 MAC halothane depressed Schaffer-collat-
eral axon fiber volleys by 18%. These findings and others
support a presynaptic action of volatile anesthetics to
depress axonal excitability.
Glutamatergic synapses are of particular interest with
regard to anesthetic mechanisms. These excitatory syn-
apses are distributed across the neural axis and are espe-
cially abundant in telencephalic structures such as
hippocampus and cortex [10,11]. Volatile anesthetics
have long been recognized to depress glutamatergic neu-
rotransmission, with evidence for both pre- and postsyn-
aptic sites of action, including actions to depress
excitability [12-14]. Some specialized glutamatergic syn-
apses have enabled investigators to specifically look at
anesthetic actions in electrically isolated presynaptic
structures. Wu et al. [15] reported that isoflurane at clini-
cal concentrations produced small reductions in spike
amplitudes in the calyx of Held. The nonlinearities in cou-
pling of excitability to Ca2+ influx and vesicle fusion pro-
duced a proportionally larger action of isoflurane to
reduce transmitter release. Ouyang et al. [16] found that
isoflurane inhibited Na channels in isolated neurohypo-
physeal nerve terminals. In addition, Sandstrom [17]
reported that isoflurane reduced presynaptic excitability
in the phylogenetically distant larval Drosophila glutama-
tergic neuromuscular junction – an effect that is also con-
sistent with Na channel inhibition.
We sought to address the question of whether isoflurane
inhibits voltage-gated Na channels to depress glutamater-
gic neurotransmission in the hippocampus. Earlier inves-
tigations found that isoflurane depressed glutamate
release from synaptosomes by inhibiting voltage-gated Ca
channels [18], although P/Q and N-type Ca channels
don't appear to be directly targeted [19,20]. Volatile anes-
thetics may directly act on presynaptic Na channels to
depress neurotransmission. Studies in the hippocampus
will help to ascertain whether volatile anesthetics gener-
ally inhibit Na+ conductance in the CNS or if this action is
more specifically associated with the specialized synapses
where it has been best documented [15,16].
Results
Tetrodotoxin depresses neurotransmission without effect 
on facilitation
Fiber volley (FV) and EPSP amplitudes were measured
with a minimum-to-baseline (MTB) algorithm and com-
pared with a measure of the rate of change for the initial
waveform slope (dV/dt). Figure 1A shows an averaged
EPSP with the two methods represented by dashed lines
(MTB) and solid lines (dV/dt, slopes). The two measures
were compared for variability by linear fits when plotted
as functions of the stimulus voltage over a 3 V range (Fig.
1A, right panels). In both cases the data obtained by the
MTB algorithm had a higher correlation coefficient than
the slope data, especially at low voltages as in the case of
FVs. This trend is also evident in Fig. 1A, (lower left) that
shows a greater scatter of slope measurements at lower
stimulus voltages at the start and end of the experiment.
Facilitation was plotted in the same panel (solid line) and
remained constant across large changes in EPSP ampli-
tudes.
Isoflurane produced a reversible depression of EPSP
amplitudes, accompanied by an increase in facilitation as
previously reported [12,21,22]. Figure 1B shows the time
course of a typical experiment in which 350 µM isoflurane
(1.5 vol %; 1 MAC) depressed EPSP amplitudes. The con-
ditioning (1st) EPSP was depressed by ~60%. The test
EPSP (2nd) was depressed by a smaller amount, which
increased facilitation by ~20% (n = 5). The actions of iso-
flurane on glutamatergic neurotransmission follow the
same pattern as when extracellular Ca2+ is reduced from 2
mM to 0.8 mM (Fig. 1C). Low external Ca2+ depressed
both conditioning and test EPSPs while facilitation
increased. By contrast, TTX (60 nM; Fig. 1D) depressed
EPSPs to about the same level as isoflurane or low Ca2+,
however TTX did not change facilitation.
Isoflurane depressed glutamatergic EPSPs over a wide
range of stimulus voltages (Fig. 2A). EPSPs uniformly
decreased in amplitude after exposure of the slice to 350
µM isoflurane (inset). Figure 2A (right) shows the relation
between FV and EPSP amplitudes. FV-EPSP relations were
obtained over a 5 V stimulus range in 0.2 V increments.
The results show isoflurane depressed EPSPs independ-
ently of the FV amplitudes (Fig. 2A, right). Isoflurane
shifted the apparent slope of the FV-EPSP relation (Fig.
2A, blue circles), which would be expected for depression
of EPSP amplitudes with no or little action on FV ampli-
tudes. This trend was also observed for experiments with
reduced external Ca2+ (0.8 mM) in which EPSPs were
reduced in amplitude and the FV-EPSP slope was shifted
in a similar manner (Fig. 2B). However, the FV-EPSP rela-
tion obtained with TTX (60 nM) was entirely dependent
on FV amplitudes (Fig. 2C). While EPSPs were depressed
by TTX, the FV-EPSP slope relation in the presence of TTXBMC Neuroscience 2006, 7:5 http://www.biomedcentral.com/1471-2202/7/5
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was unchanged (Fig. 2C, right) since all of the EPSP
depression produced by TTX was due to depression of FV
inputs.
Figure 3 shows the results of these experiments summa-
rized in a bar graph. Also shown are experiments involv-
ing perfusion with 10 µM CNQX or reduced stimulus
voltage. The FV-EPSP slope (middle panel) was reduced
significantly by isoflurane and low external Ca2+ com-
pared with TTX (p < 0.001 in each case, ANOVA). Depres-
sion of FV-EPSP slopes suggests an effect on excitation-
release coupling. On the other hand CNQX, an AMPA/
kainate receptor antagonist, also reduced the FV-EPSP
slope, presumably by a postsynaptic action. Reduction of
the stimulus voltage by 50% left the FV-EPSP slope
unchanged, which is consistent with an exclusively axonal
action and comparable to TTX treatment (Fig. 3, middle
panel).
Isoflurane significantly increased paired-pulse facilitation
(p < 0.001) as did low Ca2+ (p < 0.001) when compared
with TTX (ANOVA, Fig. 3, lower panel). By comparison,
facilitation was largely unaffected by 10 µM CNQX or
reduced stimulus voltage. Isoflurane (350 µM) depressed
the first EPSP by about the same amount as when external
Ca2+ was reduced to 0.8 mM (Fig. 3, top panel, no signifi-
cant difference, ANOVA, n = 6). However, in the same
experiments (Fig. 3, lower panel), isoflurane's action to
enhance facilitation was significantly less than low Ca2+ (p
< 0.001, ANOVA, n = 6). Because facilitation is increased
when synaptic release probability is reduced [23,24], the
actions of isoflurane appear to involve additional sites
besides those related to excitation-release coupling or
Ca2+ ion influx.
Partial reversal of isoflurane depression of EPSPs by high 
external calcium
Since low external Ca2+ produced a depressant effect like
isoflurane on glutamatergic neurotransmission, we were
interested in whether raising external Ca2+ would reverse
the actions of isoflurane. We recorded EPSPs during per-
fusion of isoflurane in ACSF with high Ca2+ (4 mM). Fig-
ure 4 shows that isoflurane depression of the first EPSP
was reversed in high Ca2+ ACSF. The reversal was signifi-
cant (Fig. 4, lower left). However, isoflurane delivered in
high Ca2+ ACSF still exerted a depressant action on the sec-
ond EPSP and facilitation was significantly decreased
from isoflurane in standard ACSF (Fig. 4, lower right).
Minimal fiber volley and somatic Na spike depression by 
isoflurane
Fiber volleys represent a summation of many action
potentials that arrive at the CA1 region following Schaffer
collateral stimulation. Due to the difficulty of patching
nerve terminal fibers to study action potentials directly,
we decided to study isoflurane actions on somatic Na cur-
rents recorded from whole cell patches on cells in the CA1
pyramidal cell layer. The perforated patch method
allowed us to reliably obtain access to the cell interior
while patching blind [25]. Currents were activated by a
voltage step to -30 mV from a holding potential of -70
mV. A 100 ms depolarizing pulse was delivered every 10
s. Representative currents in Fig. 5, left show a decrease in
amplitude and a slight delay after a 15 minute exposure of
the slice to 60 nM TTX. In a separate experiment, currents
recorded 10 minutes after exposure to 350 µM isoflurane
Depressant actions on FV-EPSP relations Figure 2
Depressant actions on FV-EPSP relations. A, (Left) Iso-
flurane (350 µM; 1.5 vol %) reduced EPSP amplitudes over a 
range of stimulus levels. Control responses are shown in 
black and isoflurane-depressed EPSPs are in blue. (Right) Iso-
flurane reduced the slope of the FV-EPSP relation (blue cir-
cles). B, (Left) EPSP amplitudes were strongly decreased 
when external Ca2+ was reduced from 2 mM to 0.8 mM. 
(Right) slope of the FV-EPSP relation was reduced by 0.8 mM 
Ca2+ (blue circles). C, (Left) reduction of EPSP and FV ampli-
tudes by tetrodotoxin (TTX; 60 nM). (Right) no change in the 
FV-EPSP relation in the presence of TTX. All FV-EPSP rela-
tions were well fit by single exponential functions.BMC Neuroscience 2006, 7:5 http://www.biomedcentral.com/1471-2202/7/5
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were indistinguishable from controls (Fig. 5, right). These
results are in general agreement with our field recording
experiments, although somatic Na channels may have dif-
ferent properties than those in terminal fibers.
Because fiber volleys are partially occluded by EPSPs (Fig.
6A), the dose-dependent action of isoflurane on fiber vol-
leys was investigated following block of glutamate recep-
tors with 2-amino-5-phosphonovaleric acid (APV; NMDA
receptor blocker, 125 µM) and 6-cyano-7-nitroquinoxa-
line-2,3-dione (CNQX; AMPA/kainate receptor blocker,
8.6 µM). This treatment eliminated EPSPs leaving only
FVs (Fig. 6A, lower panel). Observable block of FVs only
became apparent with high (3 vol %) or supraclinical (5
vol %) isoflurane (Fig. 6C). At these concentrations isoflu-
rane produced a reduction of FV amplitudes in a manner
comparable to, but not as great as 60 nM TTX (Fig 6B). FV
amplitudes were depressed in a dose-dependent manner
(Fig. 6D) with an EC50 of ~2.8 mM (12 vol. %; 8 MAC)
estimated from a least-squares fit extrapolation. But at
clinical levels, 350 µM (1 MAC) isoflurane only depressed
FV amplitudes by 1.2 ± 4.3% (n = 8). This is in contrast to
the volatile anesthetic halothane, which depressed FV
amplitudes by ~18% at 1 MAC [9], using identical record-
ing conditions.
Discussion
Volatile anesthetics are known to depress glutamatergic
synaptic transmission, although the molecular mecha-
nisms are unclear. Wu et al. [15] reported that isoflurane
inhibited presynaptic action potentials in the calyx of
Actions of isoflurane (ISO, 1 MAC), low extracellular Ca2+  (0.8 – 1.0 mM), TTX (60 nM), CNQX (10 µM) and 50% stim- ulus (STIM) voltage Figure 3
Actions of isoflurane (ISO, 1 MAC), low extracellular 
Ca2+ (0.8 – 1.0 mM), TTX (60 nM), CNQX (10 µM) 
and 50% stimulus (STIM) voltage. Experiments with 0.8 
mM and 1.0 mM external Ca2+ were pooled, as the changes 
in facilitation and EPSP depression under each condition 
were almost identical. The actions of these treatments are 
shown for EPSP depression (top panel), FV-EPSP curve slopes 
(I/O slopes; middle panel) and paired-pulse facilitation (PPF; 
lower panel). Each bar represents the mean ± standard devia-
tion for at least five experiments from different slice prepara-
tions. Note that each treatment substantially depressed 
EPSPs but only isoflurane and low Ca2+ produced a significant 
change in the I/O slope compared to TTX (p < 0.001 in both 
cases, ANOVA). PPF with isoflurane and low Ca2+ was also 
significantly greater than with TTX (p < 0.001 and p < 0.001 
respectively, ANOVA).
High external calcium partly reverses isoflurane depression  of EPSPs Figure 4
High external calcium partly reverses isoflurane 
depression of EPSPs. (Top) control EPSP pairs at left show 
the first EPSP amplitude (dashed line) and facilitation of the 
second EPSP (solid line). The center trace shows depression 
of both EPSPs in the presence of 350 µM isoflurane. The 
traces at right show reversal of isoflurane depression for the 
first EPSP and partly for the second in the presence of 350 
µM isoflurane and ACSF with [Ca2+] doubled to 4 mM. 
(Lower Left) bar graph shows reversal of isoflurane (ISF) 
depression of the first EPSP. The first EPSP amplitude was 
depressed ~50% by isoflurane, but increased significantly 
when isoflurane was delivered in ACSF containing 4 mM Ca2+ 
(ANOVA, p < 0.001, n = 6). (Lower Right) bar graph shows 
that facilitation tended to increase in the presence of isoflu-
rane but was then significantly depressed when isoflurane 
was delivered in ACSF containing 4 mM Ca2+ (ANOVA, p < 
0.01, n = 6).BMC Neuroscience 2006, 7:5 http://www.biomedcentral.com/1471-2202/7/5
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Held to reduce glutamatergic neurotransmission. We were
interested in further study of the presynaptic action of iso-
flurane, as Wu et al. [15] did not compare isoflurane and
TTX effects, nor did they look at effects on facilitation. To
test the generality of isoflurane depression of action
potentials, we studied the effects of isoflurane in compar-
ison with TTX on EPSPs in the CA1 region of the rat hip-
pocampus and on FVs recorded from presynaptic
Schaffer-collateral fibers. TTX blocks all brain Na chan-
nels, including those in the calyx of Held [26,27]. We
found that clinical concentrations of isoflurane had little
to no inhibitory action on FV amplitudes, although EPSPs
were strongly depressed and facilitation was increased.
Somatic Na currents were also unaffected by 350 µM iso-
flurane. On the other hand, TTX reduced FV amplitudes
and EPSP amplitudes but had no effect on facilitation.
TTX also had no effect on the slope of the FV-EPSP rela-
tion. The actions of TTX likely resulted in part from nerve
fiber conduction block. Fewer conducting fibers would
reduce responsiveness to the stimulating electrode and
account for the similar actions of TTX and reduced stimu-
lus voltage on paired-pulse facilitation and the FV-EPSP
relation (Fig. 3). TTX could also reduce Na spike ampli-
tudes and decrease fiber conduction velocity [28] (Fig.
6B).
Unlike TTX, isoflurane at clinical concentrations doesn't
appear to inhibit Na channel activity in hippocampal
Schaffer-collateral fibers. Depression of EPSPs and
enhancement of facilitation by isoflurane likely results
from actions downstream from Na channels at sites that
contribute more directly to excitation-release coupling, as
supported by the insensitivity of the FV-EPSP slope to TTX
(Fig. 2).
Fiber volleys in Schaffer collateral fibers represent a sum-
mation of closely-timed multiple action potentials. Their
close temporal coordination is reflected by the short dura-
tion of the fiber volley, which is typically about 5–8 ms.
Insensitivity of somatic spike currents to isoflurane Figure 5
Insensitivity of somatic spike currents to isoflurane. 
Control traces at left are four overlaid leak-subtracted 
inward spikes. The records are from a representative whole-
cell perforated patch in the pyramidal cell body layer of the 
hippocampal CA1 region. 100 ms voltage pulses to -30 mV 
were applied at 10 s intervals to elicit spikes (VH = -70 mV). 
Currents in green show four spikes recorded after a 15 min 
exposure to 60 nM TTX. At right are overlays of spike cur-
rents recorded before and after a 10 min exposure to 350 
µM isoflurane (1 MAC). The blue traces were recorded after 
exposure to isoflurane.
Depression of FVs by isoflurane Figure 6
Depression of FVs by isoflurane. A, (top) An extracellular 
recording under control conditions showing the FV is par-
tially occluded by the larger EPSP. A, (lower) The FV was iso-
lated with CNQX (8.6 µM) and APV (125 µM) to block 
AMPA/kainate and NMDA receptors, respectively. B, Partial 
block of a FV by 60 nM TTX (green trace). C, Isoflurane pro-
duced small reductions of FV amplitudes (blue traces). D, 
Concentration dependence of the depression of FV ampli-
tudes by isoflurane. Data were normalized to control condi-
tions in the absence of drug. Each point represents the mean 
of multiple experiments carried out in different slice prepara-
tions (n = 6 each data point), with standard deviations repre-
sented by the error bars. The dashed line is a least-squares fit 
to a Boltzmann relation with an EC50 = ~12 vol % and a Hill 
coefficient of 2 (χ2 = 2.5). All measurements were made fol-
lowing at least a 20 minute period for the perfusion system 
to equilibrate.BMC Neuroscience 2006, 7:5 http://www.biomedcentral.com/1471-2202/7/5
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FV-EPSP relations typically show an asymptotic decrease
at higher FV amplitudes (Fig. 2, right panels), which con-
trasts to the accelerating relation of the action potential –
EPSC relation in the calyx of Held [15]. However, Wu et al
[15] obtained their EPSC data by use of a scaled action
potential as a voltage command while we obtained EPSP
data by changing the stimulus voltage. Our methodology
reflects an experimental focus on the properties of a pop-
ulation of synapses, with results that show a broad insen-
sitivity of terminal fiber Na channels to isoflurane. Further
study is needed at individual CA1 synapses to determine
whether a subpopulation may be more sensitive to con-
duction block by isoflurane.
Elevated external Ca2+ reversed isoflurane depression of
the first EPSP. This is likely related to the enhanced release
of transmitter by increased Ca2+ influx during nerve termi-
nal depolarization. Elevated external Ca2+  may also
enhance NMDA receptor currents. However, this contri-
bution to the EPSP is likely to be small, as the proportion
of the NMDA receptor current carried by Ca2+ is fractional,
e.g. 17% of the total NR1/NR2A current [29].
Voltage-gated P/Q type Ca channels are localized at syn-
aptic terminals in many central neurons [30], including
the mature calyx of Held where they closely associate with
synaptic vesicles [31] and appear to have an important
role in paired-pulse facilitation [32]. High external [Ca2+]
will increase Ca2+  influx when Ca channels open in
response to depolarization. The result would likely
increase the synaptic release probability [33] and tend to
reduce facilitation, as we observed (Fig. 4). While P/Q Ca
channels are not strongly inhibited by volatile anesthetics
[19] there remains the possibility that volatile anesthetics
may reduce calcium-induced calcium release from inter-
nal stores, as described in dendrites of hippocampal
pyramidal cells [34] and suggested as an anesthetic mech-
anism for pentobarbitone [35].
Another possible site includes the N-ethylmaleimide-sen-
sitive factor attachment protein receptor (SNARE) com-
plex. The SNARE complex is involved in vesicle docking
and fusion at most synapses. Disruption of SNARE pro-
teins with Botulinum toxins A and F can each reduce the
initial release probability. However, Botox F doesn't pro-
duce facilitation unless external [Ca2+] is lowered [36].
Our results showing partial reversal of isoflurane effects
on neurotransmission with high external [Ca2+] suggest
the SNARE complex may warrant further study as targets
of volatile anesthetics. In fact, isoflurane and halothane
have recently been reported to bind to syntaxin and the
SNARE complex at clinical concentrations [37], although
the binding sites on the SNARE proteins have not yet been
characterized.
It is important to note that not all volatile anesthetics may
target the same molecular sites. Our results with isoflu-
rane differ from the reported actions of halothane on syn-
aptic transmission. Like isoflurane, halothane depresses
EPSP amplitudes in rat hippocampal slices at clinical con-
centrations [13]. However, halothane also depresses
Schaffer-collateral axon fiber volley amplitudes [9].
Unlike TTX, halothane has no effect on conduction veloc-
ity but does increase facilitation of EPSPs [9]. While the
dissimilar pharmacological profiles for halothane and
isoflurane are inconsistent with a unitary model of
anesthesia, both can be understood within a multi-site
model of volatile anesthetic action [38-40].
The weak depressant action of isoflurane on Schaffer-col-
lateral FVs indicates that presynaptic actions of isoflurane
are not homogeneous in the brain – especially when con-
trasted to the results reported by Ouyang et al. [16] and
Wu et al. [15]. Furthermore, Baudoux et al [35], who stud-
ied Ca2+ transients in CA1 pyramidal cell axons, con-
cluded that general anesthetics are unlikely to interfere
with action potential propagation even in fine axon col-
laterals. Factors that could affect regional variability in
action potential depression include the degree of terminal
fiber myelination [cf. [8]; although see [5]] as well as the
diversity of voltage-gated Na channel expression and sub-
cellular distribution [41]. Five TTX-sensitive Na channel
α-subunits have been reported to be expressed in hippoc-
ampal neurons: NaV1.1, NaV1.2, NaV1.3, NaV1.6 and
NaV1.7 [42], with complex patterns of expression even
between different neurons. On the other hand, Leão et al.
[27] reported that Na channels are absent from the calyx
of Held. Their immunocytochemical data show NaV1.6
but not NaV1.2 was expressed at the axonal heminodes
from which action potentials passively invade the calyx
[27,43]. These data taken together suggest that the expres-
sion pattern of Na channel α-subunits in neurons can
influence anesthetic sensitivity. In addition, α-subunits
are frequently associated with a β1 subunit that can mod-
ulate Na channel gating [44]. So it appears that there are
numerous possible isoforms of Na channels that are
expressed heterogeneously in the CNS. The degree to
which these isoforms differ with respect to volatile anes-
thetic sensitivity is presently unknown.
Conclusion
We conclude that for glutamatergic hippocampal neu-
rons, isoflurane depresses transmission downstream from
Na channels. Unlike TTX, isoflurane simultaneously
increased facilitation and depressed EPSPs with only a
minimal reduction of fiber volley amplitudes. Consistent
with previous studies, a likely mechanism of isoflurane
action is to reduce presynaptic Ca2+ levels following nerve
terminal depolarization and/or to disrupt the vesicle
release process.BMC Neuroscience 2006, 7:5 http://www.biomedcentral.com/1471-2202/7/5
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Methods
The experimental protocols were approved by the Institu-
tional Animal Care Committee at Stanford University and
adhered to the published guidelines of the NIH, the Soci-
ety for Neuroscience and The American Physiological
Society. Male Sprague-Dawley rats were anesthetized with
diethyl ether (22 vol. % in air). The animals were killed by
decapitation. Brains were rapidly removed and placed in
ice-cold (5°C) artificial cerebrospinal fluid (ACSF) that
was pre-gassed with carbogen (95%-O2/5%-CO2). The
ACSF had the following composition (in mM): 124 NaCl,
3.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 2 CaCl2, 2 MgSO4,
and 10 D-glucose. Whole brain coronal slices (400 µm)
were cut with a Vibratome Model 1500 (Technical Prod-
ucts International, Inc., O'Fallon, MO). The brain slices
were equilibrated for at least one hour at room tempera-
ture (22°C) in a humidified chamber partially filled with
ACSF and continually bubbled with carbogen. Individual
slices were transferred to a recording chamber, submerged
in ACSF and equilibrated for an additional 10 minutes
prior to electrophysiological recording. All experiments
were conducted at room temperature. Brain slices were
continuously perfused with oxygenated ACSF at a flow
rate of ~1.5 ml/min.
The inhalation anesthetic isoflurane was mixed with car-
rier gas (95%-O2/5%-CO2) in a calibrated commercial
vaporizer (Fluotec 3, Fraser Harlake, Orchard Park, NY)
and bubbled into the ACSF reservoir that perfused the
brain slices. This system has been previously calibrated for
delivery of volatile anesthetics [45]. In some experiments
the perfusion solution included 2-amino-5-phosphono-
valeric acid (APV; NMDA receptor blocker, 125 µM) and
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; AMPA/
Kainate receptor blocker, 8.6 µM) to block EPSPs.
Bipolar tungsten microelectrodes were placed on Schaffer-
collateral fibers to electrically stimulate inputs to hippoc-
ampal CA1 pyramidal neurons. Glass micropipettes (Gar-
ner Glass, Claremont, CA) were pulled with a resistance of
2–5 MΩ, filled with ACSF and placed in stratum radiatum
to record stimulus-evoked fiber volleys and excitatory
postsynaptic potentials. Paired stimulus pulses (3–6 V,
300 µs duration; 80 ms interpulse interval) were delivered
by a Grass stimulation isolation unit from a two-channel
stimulator at a stimulus rate of 0.05 Hz. The field poten-
tials were amplified, low-pass filtered at 20 kHz and sam-
pled at 25 µs.
All responses were measured with DataWave or PClamp
software and analyzed with IGOR Pro (WaveMetrics, Lake
Oswego, OR). Fiber volley and EPSP amplitudes were
measured from peak negative voltage to baseline (mini-
mum-to-baseline) or alternatively, their initial slopes
were measured between 20% and 80% of minimum. All
responses were normalized as a percent of control, based
on average amplitudes from a 20 min recording immedi-
ately before drug perfusion. We used InStat 3 (GraphPad
Software, Inc.) to compare anesthetic effects between
groups of time-matched experiments (two-way analysis of
variance; ANOVA).
Perforated patch recordings
Whole cell currents were recorded from patches in the
pyramidal cell body layer of the CA1 region of hippocam-
pal slices. Slices were perfused with ACSF as described
above. Patch electrodes were pulled from Garner KG-33
glass. The recording micropipette resistances ranged from
4–6 MΩ and seal resistances ranged from 1–5 GΩ. The
patch electrode-filling solution contained (in mM) 140
potassium gluconate, 10 HEPES, 0.2 EGTA, 2 MgCl2, 0.10
CaCl2, 2 Na2-ATP, 0.3 Na-GTP (pH 7.4; free Ca2+ ~100
nM). To obtain perforated patches, a stock solution of 100
mM amphotericin B (Sigma-Aldrich, St. Louis, MO) was
prepared in DMSO and stored at -20°C. The stock solu-
tion was diluted (1/1000) into the pipette solution and
sonicated for ~30 s to obtain a final amphotericin B con-
centration of 100 µM. Before seal formation, the voltage
offset between the patch electrode and the bath solution
was adjusted to produce zero current. Whole cell currents
were recorded with an Axon Instruments MultiClamp
700A amplifier and PClamp software (Molecular Devices,
Union City, CA). All experiments were performed at room
temperature (~21–23°C).
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